VIVOS THERAPEUTICS INC (VVOS) Stock Price & Overview
NASDAQ:VVOS • US92859E2072
The current stock price of VVOS is 1.33 USD. Today VVOS is down by 0%. In the past month the price decreased by -14.19%. In the past year, price decreased by -59.7%.
VVOS Key Statistics
- Market Cap
- 12.555M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.77
- Dividend Yield
- N/A
VVOS Stock Performance
VVOS Stock Chart
VVOS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to VVOS. When comparing the yearly performance of all stocks, VVOS is a bad performer in the overall market: 94.48% of all stocks are doing better.
VVOS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VVOS. VVOS has a bad profitability rating. Also its financial health evaluation is rather negative.
VVOS Earnings
On November 19, 2025 VVOS reported an EPS of -0.49 and a revenue of 6.78M. The company beat EPS expectations (5.81% surprise) and beat revenue expectations (38.2% surprise).
VVOS Forecast & Estimates
9 analysts have analysed VVOS and the average price target is 5.1 USD. This implies a price increase of 283.46% is expected in the next year compared to the current price of 1.33.
For the next year, analysts expect an EPS growth of 28.96% and a revenue growth 27.39% for VVOS
VVOS Groups
Sector & Classification
VVOS Financial Highlights
Over the last trailing twelve months VVOS reported a non-GAAP Earnings per Share(EPS) of -1.77. The EPS increased by 68.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.7% | ||
| ROE | -675.51% | ||
| Debt/Equity | 3.36 |
VVOS Ownership
VVOS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.79 | 99.131B | ||
| CI | THE CIGNA GROUP | 8.62 | 71.564B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 100.5 | 26.592B | ||
| LH | LABCORP HOLDINGS INC | 15.19 | 22.356B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.77 | 21.887B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.75B | ||
| DVA | DAVITA INC | 10.79 | 10.071B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.45 | 8.03B | ||
| CHE | CHEMED CORP | 16.64 | 5.617B | ||
| RDNT | RADNET INC | 78.34 | 4.696B | ||
| OPCH | OPTION CARE HEALTH INC | 15.56 | 4.668B | ||
| HNGE | HINGE HEALTH INC-A | 23.82 | 3.632B | ||
| HIMS | HIMS & HERS HEALTH INC | 40.58 | 3.588B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VVOS
Company Profile
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.
Company Info
VIVOS THERAPEUTICS INC
7921 Southpark Plaza,, Suite 210
Littleton COLORADO US
Employees: 109
Phone: 18669084867
VIVOS THERAPEUTICS INC / VVOS FAQ
What does VIVOS THERAPEUTICS INC do?
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.
Can you provide the latest stock price for VIVOS THERAPEUTICS INC?
The current stock price of VVOS is 1.33 USD.
Does VIVOS THERAPEUTICS INC pay dividends?
VVOS does not pay a dividend.
What is the ChartMill technical and fundamental rating of VVOS stock?
VVOS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the expected growth for VVOS stock?
The Revenue of VIVOS THERAPEUTICS INC (VVOS) is expected to grow by 27.39% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for VIVOS THERAPEUTICS INC?
VIVOS THERAPEUTICS INC (VVOS) currently has 109 employees.